How do comorbidities impact treatment decisions? What comorbidities are most prevalent in newly diagnosed myeloma patients

How do comorbidities impact treatment decisions? What comorbidities are most prevalent in newly diagnosed myeloma patients
What are the biggest challenges to being able to offer effective immunotherapy options to acute myeloid leukemia patients?
What is Immunoparesis? Why does it occur? How is it managed?
What is risk stratification and why is knowing risk status important?
What type of tests are performed to determine eligibility for transplant?
What is hyperviscosity, why does it occur and how it it managed?
In what setting do you see immunotherapy being the most effective?